• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by CynergisTek Inc. (Amendment)

    6/1/22 1:13:47 PM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology
    Get the next $CTEK alert in real time by email
    SC 13D/A 1 sc13da311238006_06012022.htm AMENDMENT NO. 3 TO THE SCHEDULE 13D

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    SCHEDULE 13D

    (Rule 13d-101)

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO

    § 240.13d-2(a)

    (Amendment No. 3)1

    Cynergistek, Inc.

    (Name of Issuer)

    Common Stock, $0.001 par value

    (Title of Class of Securities)

    23258P105

    (CUSIP Number)

    ANDREW FREEDMAN, ESQ.

    MEAGAN REDA, ESQ.

    OLSHAN FROME WOLOSKY LLP

    1325 Avenue of the Americas

    New York, New York 10019

    (212) 451-2300

    (Name, Address and Telephone Number of Person

    Authorized to Receive Notices and Communications)

     

    May 23, 2022

    (Date of Event Which Requires Filing of This Statement)

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ☒.

    Note:  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See § 240.13d-7 for other parties to whom copies are to be sent.

     

     

     

    1              The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

    CUSIP No. 23258P105

      1   NAME OF REPORTING PERSON  
             
            HORTON CAPITAL MANAGEMENT, LLC  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            WC, OO (See Item 3)  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            DELAWARE  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         - 0 -  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         525,170* (See Item 5)  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              - 0 -  
        10   SHARED DISPOSITIVE POWER  
               
              525,170* (See Item 5)  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            525,170* (See Item 5)  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            3.8% (See Item 5)  
      14   TYPE OF REPORTING PERSON  
             
            IA; OO  

      

    *Includes 524,170 Shares underlying the Initial Warrant (as defined and described in Item 3) that is currently exercisable.

    2

    CUSIP No. 23258P105

      1   NAME OF REPORTING PERSON  
             
            HORTON CAPITAL PARTNERS FUND, LP  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            WC, OO (See Item 3)  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            DELAWARE  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         - 0 -  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         525,170* (See Item 5)  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              - 0 -  
        10   SHARED DISPOSITIVE POWER  
               
              525,170* (See Item 5)  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            525,170* (See Item 5)  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            3.8% (See Item 5)  
      14   TYPE OF REPORTING PERSON  
             
            PN  

      

    *Includes 524,170 Shares underlying the Initial Warrant that is currently exercisable.

    3

    CUSIP No. 23258P105

     

      1   NAME OF REPORTING PERSON  
             
            HORTON CAPITAL PARTNERS, LLC  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            OO (See Item 3)  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            DELAWARE  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         - 0 -  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         525,170* (See Item 5)  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              - 0 -  
        10   SHARED DISPOSITIVE POWER  
               
              525,170* (See Item 5)  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            525,170* (See Item 5)  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            3.8% (See Item 5)  
      14   TYPE OF REPORTING PERSON  
             
            OO  

      

    *Includes 524,170 Shares underlying the Initial Warrant that is currently exercisable.

    4

    CUSIP No. 23258P105

     

      1   NAME OF REPORTING PERSON  
             
            JOSEPH M. MANKO, JR.  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            OO (See Item 3)  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            UNITED STATES OF AMERICA  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         - 0 -  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         525,170* (See Item 5)  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              - 0 -  
        10   SHARED DISPOSITIVE POWER  
               
              525,170* (See Item 5)  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            525,170* (See Item 5)  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            3.8% (See Item 5)  
      14   TYPE OF REPORTING PERSON  
             
            IN  

      

    *Includes 524,170 Shares underlying the Initial Warrant that is currently exercisable.

    5

    CUSIP No. 23258P105

      

    The following constitutes Amendment No. 3 to the Schedule 13D filed by the undersigned (“Amendment No. 3”). This Amendment No. 3 amends the Schedule 13D as specifically set forth herein.

    Item 3.Source and Amount of Funds or Other Consideration.

    Item 3 is hereby amended and restated to read as follows:

    The Shares purchased by HCPF were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market purchases, except as otherwise noted.

    The aggregate purchase price of the 1,000 Shares directly owned by HCPF is approximately $1,458.00, excluding brokerage commissions.

    On April 3, 2020, HCM entered into the Securities Purchase Agreement (as defined and described in Item 4 of Amendment No. 1 to the Schedule 13D) with the Issuer. In consideration for its obligations under the Securities Purchase Agreement, HCM received a warrant (the “Initial Warrant”), with a 10-year term, to purchase up to 500,000 Shares (the “Warrant Shares”), for an exercise price of $2.50 per share, subject to certain anti-dilution adjustments and limitations, as set forth in the Initial Warrant, including a conversion cap which precludes the Holder (as defined in the Securities Purchase Agreement) from exercising all or a portion of the Initial Warrant if, after such exercise, such Holder would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 9.99% of the Shares outstanding immediately after giving effect to such exercise (the “9.99% Beneficial Ownership Limitation”). On April 7, 2020, HCM transferred the Initial Warrant to HCPF.

    Item 5.Interest in Securities of the Issuer.

    Item 5 is hereby amended and restated to read as follows:

    The aggregate percentage of Shares reported owned by each person named herein is based upon a denominator that is the sum of: (i) 13,256,570 Shares outstanding, as of May 17, 2022, which is the total number of Shares outstanding as reported in that certain Agreement and Plan of Merger, dated May 23, 2022, which was filed as an exhibit to the Issuer’s Form 8-K filed with the Securities and Exchange Commission on May 23, 2022, and (ii) the 524,170 Shares underlying the Initial Warrant.

    A.HCPF
    (a)As of June 1, 2022, HCPF beneficially owned 525,170 Shares, including 524,170 Shares underlying the Initial Warrant.

    Percentage: Approximately 3.8%

    (b)1. Sole power to vote or direct vote: 0
    2. Shared power to vote or direct vote: 525,170
    3. Sole power to dispose or direct the disposition: 0
    4. Shared power to dispose or direct the disposition: 525,170

     

    (c)The transactions in the Shares by HCPF during the past sixty days are set forth in Schedule A and are incorporated herein by reference.
    6

    CUSIP No. 23258P105

    B.HCP
    (a)As the general partner of HCPF, HCP may be deemed the beneficial owner of the 525,170 Shares beneficially owned by HCPF, including 524,170 Shares underlying the Initial Warrant.

    Percentage: Approximately 3.8%

    (b)1. Sole power to vote or direct vote: 0
    2. Shared power to vote or direct vote: 525,170
    3. Sole power to dispose or direct the disposition: 0
    4. Shared power to dispose or direct the disposition: 525,170

     

    (c)HCP has not entered into any transactions in the Shares during the past sixty days. The transactions in the Shares on behalf of HCPF during the past sixty days are set forth in Schedule A and are incorporated herein by reference.
    C.HCM
    (a)As the investment manager of HCPF, HCM may be deemed the beneficial owner of the 525,170 Shares beneficially owned by HCPF, including 524,170 Shares underlying the Initial Warrant.

    Percentage: Approximately 3.8%

    (b)1. Sole power to vote or direct vote: 0
    2. Shared power to vote or direct vote: 525,170
    3. Sole power to dispose or direct the disposition: 0
    4. Shared power to dispose or direct the disposition: 525,170

     

    (c)HCM has not entered into any transactions in the Shares during the past sixty days. The transactions in the Shares on behalf of HCPF during the past sixty days are set forth in Schedule A and are incorporated herein by reference.
    D.Mr. Manko
    (a)As the Managing Member of each of HCP and HCM, Mr. Manko may be deemed the beneficial owner of the 525,170 Shares beneficially owned by HCPF, including 524,170 Shares underlying the Initial Warrant.

    Percentage: Approximately 3.8%

    (b)1. Sole power to vote or direct vote: 0
    2. Shared power to vote or direct vote: 525,170
    3. Sole power to dispose or direct the disposition: 0
    4. Shared power to dispose or direct the disposition: 525,170

     

    (c)Mr. Manko has not entered into any transactions in the Shares during the past sixty days. The transactions in the Shares on behalf of HCPF during the past sixty days are set forth in Schedule A and are incorporated herein by reference.

    7

    CUSIP No. 23258P105

    The filing of this Schedule 13D shall not be deemed an admission that the Reporting Persons are, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, the beneficial owners of any securities of the Issuer that he or it does not directly own. Each of the Reporting Persons specifically disclaims beneficial ownership of the securities reported herein that he or it does not directly own.

    (d)No person other than the Reporting Persons is known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, the Shares.
    (e)As of May 23, 2022, the Reporting Persons ceased to beneficially own more than 5% of the outstanding Shares of the Issuer.

    8

    CUSIP No. 23258P105

     

    SIGNATURES

    After reasonable inquiry and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

    Dated: June 1, 2022 HORTON CAPITAL PARTNERS FUND, LP
         
      By: Horton Capital Partners, LLC, its general partner
         
      By: /s/ Joseph M. Manko, Jr.
      Name: Joseph M. Manko, Jr.
      Title: Managing Member
       
       
      HORTON CAPITAL PARTNERS, LLC
       
      By: /s/ Joseph M. Manko, Jr.
      Name: Joseph M. Manko, Jr.
      Title: Managing Member
       
       
      HORTON CAPITAL MANAGEMENT, LLC
       
      By: /s/ Joseph M. Manko, Jr.
      Name: Joseph M. Manko, Jr.
      Title: Managing Member
       
       
      /s/ Joseph M. Manko, Jr.
      JOSEPH M. MANKO, JR.

      

    9

    CUSIP No. 23258P105

    SCHEDULE A

    Transactions in the Shares During the Past Sixty Days

    HORTON CAPITAL PARTNERS FUND, LP 

    Date of Sale Amount of Shares Sold Price ($)
         
    5/23/2022 (690,654) 1.1086
    5/24/2022 (69,900) 1.1828

     

    Get the next $CTEK alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CTEK

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CTEK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CynergisTek Inc. Stockholders Approve Merger Agreement

    CynergisTek, Inc. (NYSE:CTEK), ("CynergisTek"), a leading cybersecurity, privacy, compliance, and IT audit firm helping organizations in highly regulated industries navigate emerging security and privacy issues, today announced that its stockholders have voted to approve the previously announced merger agreement dated May 23, 2022 ("Merger Agreement") with Clearwater Compliance LLC ("Clearwater"), a healthcare focused cybersecurity, compliance, and risk management solutions firm, and approval of the proposed merger contemplated by the Merger Agreement in an all cash transaction that values CynergisTek at approximately $17.7 million (the "Merger"). CynergisTek today held its virtual special

    8/31/22 4:50:00 PM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    DMG Announces Change of Directors

    VANCOUVER, British Columbia, Aug. 22, 2022 (GLOBE NEWSWIRE) -- DMG Blockchain Solutions Inc. (TSXV:DMGI) (OTC:DMGGF) (FRANKFURT: 6AX) ("DMG" or the "Company"), a vertically integrated blockchain and cryptocurrency technology company, announces John D. (J.D.) Abouchar has been appointed as a new independent Board Director and member of the Audit Committee. DMG also announces that independent Board Director, Nick Seto has resigned, effective August 22, 2022. Mr. Seto has served on DMG's board for three years and has stepped into a new consulting role for DMG. We thank him for his service since DMG's early days of mining. Mr. Abouchar brings a wealth of experience to the DMG board. He is th

    8/23/22 12:34:24 AM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    Global Healthcare Technology Leader Renews Multiple Contract Extensions Worth Over $300,000

    CynergisTek to provide its Data Privacy Compliance services to support ongoing data collection and processing activities CynergisTek, Inc. (NYSE:CTEK), leading cybersecurity, privacy, compliance, and IT audit firm helping organizations in highly regulated industries navigate emerging security and privacy issues, announces a well-known medical device manufacturer is renewing multiple Data Privacy and Compliance contract extensions worth over $300,000. The globally recognized organization is extending its seven-year relationship with CynergisTek into 2023 to support its operations in 150 countries. CynergisTek is providing its long-standing client with robust Data Privacy Program Support se

    8/15/22 3:00:00 PM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    $CTEK
    SEC Filings

    View All

    SEC Form EFFECT filed by CynergisTek Inc.

    EFFECT - CYNERGISTEK, INC (0001011432) (Filer)

    9/20/22 12:15:24 AM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    SEC Form 15-12G filed by CynergisTek Inc.

    15-12G - CYNERGISTEK, INC (0001011432) (Filer)

    9/13/22 3:53:45 PM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    SEC Form S-8 POS filed by CynergisTek Inc.

    S-8 POS - CYNERGISTEK, INC (0001011432) (Filer)

    9/13/22 3:51:00 PM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    $CTEK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Mcmillan Michael Henry returned 663,333 shares to the company, closing all direct ownership in the company

    4 - CYNERGISTEK, INC (0001011432) (Issuer)

    9/1/22 2:20:14 PM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    SEC Form 4: Mccashin Robert gave a grant of 35,000 shares and returned 99,500 shares to the company, closing all direct ownership in the company

    4 - CYNERGISTEK, INC (0001011432) (Issuer)

    9/1/22 2:15:03 PM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    SEC Form 4: Meadows Theresa Zak was granted 25,000 shares and returned 89,500 shares to the company, closing all direct ownership in the company

    4 - CYNERGISTEK, INC (0001011432) (Issuer)

    9/1/22 2:11:32 PM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    $CTEK
    Leadership Updates

    Live Leadership Updates

    View All

    Tim McMullen Joins CynergisTek as Chief Operating Officer

    CynergisTek, Inc. (NYSE:CTEK), a leader in healthcare cybersecurity, privacy, and compliance, today announces the appointment of healthcare veteran, Tim McMullen, to the position of Chief Operating Officer. McMullen was most recently president of provider solutions at EMIDS Technology, a leading provider of digital transformation solutions to the healthcare industry, serving payers, providers, life sciences, and technology firms. "I am excited to join the CynergisTek team. What I found most compelling was the team's undisputed reputation in the healthcare cybersecurity, privacy, compliance, and IT audit space, and their recent leadership position providing Cybersecurity Maturity Model Cert

    10/13/21 1:00:00 PM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    CynergisTek Expands Expertise in Capital Markets, Investment Banking and Corporate Governance on its Board of Directors

    CynergisTek, Inc. (NYSE:CTEK), a leader in cybersecurity, privacy, and compliance, today announced that it has appointed John Flood to its board of directors. John was a founding partner of Craig-Hallum Capital Group ("Craig-Hallum"), an equity research, trading, and investment banking firm supporting the company's visibility in the public market, on their access to high-quality institutional investors, and their stock's liquidity and trading profile. At Craig-Hallum, Mr. Flood led the investment banking and institutional equity sales teams. He was also a member of the firm's board of governors, and executive, research, banking, and M&A committees. Mr. Flood will be added to the audit commi

    8/13/21 9:00:00 AM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    CynergisTek, Inc. Announces the Return of Mac McMillan as CEO and President to Lead Next Phase of Growth

    CynergisTek, Inc. (NYSE:CTEK), a leader in healthcare cybersecurity, privacy, and compliance, today announced the re-appointment of the Company's founder, Mac McMillan, to the positions of Chief Executive Officer and President effective immediately. Mr. Barlow will stay on for the next 30 days to support the transition. "I want to thank Caleb Barlow for his leadership through a very difficult period during the pandemic and his efforts to support our diversification strategy with CynergisTek being the first organization to successfully pass the Cybersecurity Maturity Model Certification (CMMC) Level 3 certification as an Authorized CMMC Third Party Assessor Organization (C3PAO). Caleb has p

    7/26/21 5:30:00 PM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    $CTEK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by CynergisTek Inc.

    SC 13G - CYNERGISTEK, INC (0001011432) (Subject)

    6/3/22 4:44:55 PM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    SEC Form SC 13D/A filed by CynergisTek Inc. (Amendment)

    SC 13D/A - CYNERGISTEK, INC (0001011432) (Subject)

    6/1/22 1:13:47 PM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    SEC Form SC 13G/A filed

    SC 13G/A - CYNERGISTEK, INC (0001011432) (Subject)

    2/16/21 11:25:43 AM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    $CTEK
    Financials

    Live finance-specific insights

    View All

    CynergisTek Files First Quarter 2022 Financial Results

    CynergisTek, Inc. (NYSE:CTEK) (the "Company" or "CynergisTek"), a leader in cybersecurity, privacy, and compliance, today announced financial results for the three months ended March 31, 2022. First Quarter Summary of Financial Results for Q1 2022 compared to Q1 2021: Revenue increases 12% to $4.7 million compared to $4.2 million. Gross margin improves to 40% compared to 38%, after adjusting Q1 2021 for the employee retention credits. Net loss was unchanged at $0.9 million. Adjusted EBITDA loss was unchanged at $0.6 million. First Quarter 2022 Operational Highlights 22% increase in sequential revenue growth since Q3 2021 through Q1 2022. 32% increase in professional services

    5/16/22 4:01:00 PM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    CynergisTek Will Host Conference Call on Monday, May 16, 2022, to Discuss First-Quarter 2022 Financial Results

    CynergisTek (NYSE:CTEK), leading cybersecurity, privacy, compliance, and IT audit firm helping organizations in highly regulated industries navigate emerging security and privacy issues, today announced that management will host a conference call at 4:30 p.m. Eastern Time on Monday, May 16, 2022, to discuss first-quarter 2022 financial results. The results will be released prior to the call. Date: Monday, May 16, 2022 Time: 4:30 p.m. ET / 1:30 p.m. PT U.S.: 1-888-394-8218 International: 1-786-789-4776 Conference ID: 8001259 Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=W6CXE7Cj A replay of the call will be available from 7:30 p.m. ET on May 16, 2022 to 11:59 p.m.

    5/13/22 3:56:00 PM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    CynergisTek Reports Fourth Quarter and Full Year 2021 Financial Results

    CynergisTek, Inc. (NYSE:CTEK) (the "Company" or "CynergisTek"), a leader in cybersecurity, privacy, and compliance, today announced financial results for the three and twelve months ended December 31, 2021. Q4 and Full Year 2021 Operational Highlights 16% sequential revenue growth and 4% improvement to gross margins from Q3 to Q4 2021. 23% increase in bookings in the second half of the year when compared to the first. 15% increase of presold revenue to $20.0 million from Q1 to Q4 2021. 43 new customers added during the year. "Our focus in the second half of the year was on sales and operational improvements that would drive growth," said Mac McMillan, President and CEO of Cynergi

    3/24/22 4:01:00 PM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology